The Association of Innovative Pharmaceutical Manufacturers founded in 1992 represents 26 research and development oriented pharmaceutical companies in Hungary, which are determinant participants on the foreign and Hungarian pharmaceutical market, and account for more than 50% of the domestic medicine turnover. The parent companies of the member firms do ground-breaking work in improving general health and quality of life via the invention and development of novel innovative medicines that present a breakthrough in the treatment of diseases that cannot be treated at all or not with the proper efficacy. The activities of our innovative member companies significantly contribute to improving the general health and the quality of life of Hungarian patients.
One of the most important objectives of the Association is to ensure that medical solutions based on modern discoveries are accessible for the Hungarian population. We also strive to strengthen the relationships between our members, as well as to provide information and education.
As a professional partner, we cooperate with governmental, financial, healthcare and patient organisations in order to improve the efficiency of the Hungarian economy and healthcare system.
As a member of the European Federation of Pharmaceutical Industries and Associations (EFPIA), and an organisation with a widespread international background through its member companies, the Association of Innovative Pharmaceutical Manufacturers plays an active role in involving Hungary in European programmes that aim at more efficient healing, fruitful research and development, as well as improvement in the population’s health-related awareness.